We use AI to improve existing diagnostic tools, such as dermoscopes, supporting more accurate detection of skin cancer and other dermatological conditions and helping clinicians make more reliable decisions in everyday practice.
Our proprietary AI algorithms combine dermatological expertise with deep learning to deliver unparalleled diagnostic accuracy.
Reconstruction of rich hyperspectral data from standard dermoscopy images, revealing tissue characteristics invisible to the naked eye.
Advanced neural networks trained thousands of dermatological images for precise pattern recognition and skin cancer detection.
We work with healthcare professionals from leading medical and research institutions to ensure our technology is rigorously validated and seamlessly integrates into the clinical workflow.
From early screening to precise diagnosis and surgical excision, we support the entire clinical workflow.
Screening and triage system designed to rapidly differentiate between malignant and benign lesions in the early stages.
Clinical-grade identification of various skin conditions, including skin cancer and benign lesions.
Real-time assistance for defining precise lesion margins during surgery.
Specally was founded by a team of two medical physicists and an experimental oncologist with 15+ years of combined experience in the field. We are a research-led, innovation-driven and clinically focused medtech startup at the forefront of revolutionizing skin cancer detection through next-generation imaging technology and artificial intelligence.
Our mission is to make advanced dermatological diagnostics accessible to healthcare providers worldwide, enabling early skin cancer detection and improved patient outcomes.
Ready to transform your dermatology practice? Contact us to learn more about our solutions and for collaboration.